Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

IRON

$78.582.80%-2.26

Nachbörslich: 78.62+0.04 +0.05%

Disc Medicine Inc (IRON)

Date: O: H: L: C: Vol:

Disc Medicine Inc Aktie (IRON) Neueste Nachrichten

Four Disc Medicine conference chats will be webcast live in November - Stock Titan

Form 13D/A DISC MEDICINE For: 26 October By Investing.com - Investing.com South Africa

Form 13D/A DISC MEDICINE For: 26 October By Investing.com - Investing.com UK

Warrants exercisable at $0.0001 a share feature in Disc Medicine (IRON)'s ownership amendment. - Stock Titan

Form 4 Disc Medicine Inc: Kevin Bitterman (Director) For: 19 October By Investing.com - Investing.com South Africa

Disc Medicine Raises $450 Million in Public Offering to Extend Cash Runway Into 2030 - TradingView

WilmerHale Advises Underwriters in Disc Medicine’s Upsized $450 Million Public Offering - WilmerHale

Form 4 Disc Medicine Inc: Kevin Bitterman (Director) For: 19 October - Investing.com Nigeria

Form 424B5 Disc Medicine Inc For: 21 October By Investing.com - Investing.com Canada

Form 424B5 Disc Medicine Inc For: 21 October By Investing.com - Investing.com UK

Disc Medicine director Bitterman sells $3.35m in shares By Investing.com - Investing.com Australia

Form 4 Disc Medicine Inc: Kevin Bitterman (Director) For: 19 October - Investing.com Australia

Planned sales of 41,825 shares in Disc Medicine (IRON) spanned nine transactions. - Stock Titan

A 6 million-share offering would help fund bitopertin development at Disc Medicine (IRON). - Stock Titan

Atlas Venture Fund XII's proposed share sale in Disc Medicine (Nasdaq: IRON) totals $21.1K. - Stock Titan

A Disc Medicine (IRON) holder proposes selling 11,470 shares valued at $912K. - Stock Titan

Merrill Lynch is listed to broker a proposed sale of 13,783 Disc Medicine (Nasdaq: IRON) shares. - Stock Titan

A shareholder proposes selling 33,461 Disc Medicine (Nasdaq: IRON) shares valued at $2.66M. - Stock Titan

Disc Medicine Prices $450 Million Offering at $75 a Share - TOKENPOST

Disc Medicine prices $450 million stock offering at $75/share By Investing.com - Investing.com Australia

Disc Medicine prices $450 million stock offering at $75/share - Investing.com

Disc Medicine prices $450 million stock offering at $75/share By Investing.com - Investing.com South Africa

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock - The Manila Times

Disc Medicine Announces Pricing of Upsized $450 Million Public Offering - Quiver Quantitative

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock - www.marketscreener.com

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock - The Daily Tribune News

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock - GlobeNewswire Inc.

A stock sale is expected to bring Disc Medicine $450 million before expenses, if no extra shares are bought. - Stock Titan

A holder proposes selling 55 shares of Disc Medicine (Nasdaq: IRON). - Stock Titan

Disc Medicine follows up positive bitopertin Phase III with USD 350m offering - AllSci

Disc Medicine: APOLLO Changes The Story, But How Much Upside Remains (NASDAQ:IRON) - Seeking Alpha

Disc Medicine (IRON) Launches $350M Stock Offering to Fund Clini - GuruFocus

A fund proposes selling 5,937 Disc Medicine (Nasdaq: IRON) shares through Merrill Lynch. - Stock Titan

A shareholder proposes selling 14,414 Disc Medicine (IRON) shares through Merrill Lynch. - Stock Titan

A proposed sale of 115 Disc Medicine (IRON) shares comes from Atlas Venture Fund XII. - Stock Titan

Disc Medicine launches $350 million stock offering By Investing.com - Investing.com Canada

Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Disc Medicine launches $350M public offering of common stock and pre-funded warrants - TradingView

Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants - www.marketscreener.com

IRON Stock Jumps As APOLLO Phase 3 Data Webcast Nears - Timothy Sykes

In month six, patients on a trial drug had 12.2 more pain-free hours in sunlight than the comparison group - Stock Titan

Disc Medicine launches $350 million stock offering By Investing.com - Investing.com South Africa

Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP) - GlobeNewswire Inc.

A drug's late-stage trial results will be discussed Monday. - Stock Titan

735,300 Disc Medicine, Inc. $IRON Shares Acquired by Assenagon Asset Management S.A. - MarketBeat

Disc Medicine, Inc. (NASDAQ:IRON) Stock Has Average Target Price of $110.18 - MarketBeat

IRON S-8 & SEC Filings - Yahoo Finance - Yahoo! Finance Canada

Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.

A subsidiary holds the shares behind Abu Dhabi Investment Authority’s Eikon Therapeutics (EIKN) stake. - stocktitan.net

Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire

Ähnlich wie IRON

ACAD$20.460.63%

TARS$73.391.95%

VKTX$26.821.69%

ABCL$11.129.41%

PBLS$27.273.71%